[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vicarious Surgical director David D. Ho reported the grant of a stock option covering 5,335 shares of Class A common stock in a Form 4 filed for the issuer Vicarious Surgical Inc. (RBOT). The option has an exercise/conversion price of $7.61, a transaction date of 06/27/2025, and an expiration date of 06/26/2035. The filing shows the reporting person holds 5,335 shares underlying the option following the reported transaction, held in a direct ownership form.

The grant was reported by an attorney-in-fact, signed on 08/11/2025. Per the explanatory note, the option shares will vest on June 27, 2026 (or one day before the next annual meeting), subject to continued service. No earnings or other company financial data are included in this Form 4.

Positive

• Director alignment: Grant of 5,335 options aligns the director's incentives with shareholder outcomes through equity ownership.
• Clear vesting schedule: Vesting on June 27, 2026 (or one day before the next annual meeting) promotes retention and multi-year alignment.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: A routine director equity grant of 5,335 options aligns management with shareholders but appears customary and not immediately dilutive.

The Form 4 documents a stock option grant to Director David D. Ho for 5,335 Class A shares with a $7.61 exercise price and a 06/26/2035 expiration. Vesting is scheduled for 06/27/2026 subject to continued service, which is consistent with standard retention-oriented equity awards for directors. The grant was reported as direct ownership and executed via attorney-in-fact. For governance review, key points are the one-year vesting horizon and the long expiration term; neither element alone suggests unusual governance risk, though the absolute dilutive impact depends on total outstanding shares (not provided).

Compensation Analyst

TL;DR: This appears to be a standard option award aimed at director retention; materiality to shareholders cannot be assessed from this form alone.

The award size (5,335 options) and terms—$7.61 strike, vesting June 27, 2026, expiration June 26, 2035—fit common director compensation profiles that provide multi-year alignment. The transaction price field shows $0.00 for the grant transaction, consistent with a standard option issuance rather than a purchased option. Without the company's total share count or grant history, the compensation impact and potential dilution are not determinable from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ho David D

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.61	06/27/2025		A		5,335		(1)	06/26/2035	Class A Common Stock	5,335	$0.00	5,335	D

Explanation of Responses:

1. All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.

	/s/ Erin Checka, Attorney-in-Fact	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did David D. Ho report for Vicarious Surgical (RBOT)?

The Form 4 reports a grant of a stock option covering 5,335 Class A shares with a $7.61 exercise price, transaction date 06/27/2025.

When do the options vest and when do they expire?

Per the filing note, the options vest on June 27, 2026 (or one day prior to the next annual meeting) subject to continued service; expiration is 06/26/2035.

How many shares does the reporting person beneficially own after the transaction?

The filing shows the reporting person beneficially owns 5,335 shares underlying the option following the reported transaction.

Who signed and filed the Form 4 for this transaction?

The Form 4 is signed by /s/ Erin Checka, Attorney-in-Fact with a signature date of 08/11/2025.

Does the Form 4 indicate the transaction was part of a 10b5-1 plan?

No. The filing does not indicate that the transaction was made pursuant to a 10b5-1 trading plan (no such plan box is marked in the content provided).